Drug-induced hyperthermia and rhabdomyolysis during the perioperative period: Report of three patients

Journal of the Medical Association of Thailand

Volumn 85, Issue SUPPL. 3, 2002, Pages

  Vorrakitpokatorn, Puthipanee ^a   Limsakul, Aticha ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Amphetamine; Drug Abuse; Malignant Hyperthermia; Rhabdomyolysis

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; HALOTHANE; ISOFLURANE; SEROTONIN UPTAKE INHIBITOR; SEVOFLURANE; SUXAMETHONIUM;

ADULT; ANESTHESIA INDUCTION; ANESTHESIST; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; EARLY DIAGNOSIS; FEMALE; HUMAN; HYPERTHERMIA; MALE; MALIGNANT HYPERTHERMIA; MORBIDITY; MORTALITY; MYALGIA; PERIOPERATIVE PERIOD; RHABDOMYOLYSIS; RIGIDITY; TACHYCARDIA;

ADULT; AMPHETAMINES; ANESTHETICS, INHALATION; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTRAOPERATIVE PERIOD; MALE; MALIGNANT HYPERTHERMIA; RHABDOMYOLYSIS;

EID: 0036764234     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. nd Ed. St. Louis: Mosby, 1999: 338-56.
2. Farmer JC. Temperature-related injuries. In: Civetta JM, Taylor RW, Kirby RB, eds. Critical Care. Philadelphia: Lippincott-Raven Publ, 1997: 1451-62.
3. Mikhail MS, Thangathurai D. Hyperthermia. In: Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC, eds. Textbook of Critical Care. Philadelphia: WB Saunders Co, 2000: 217-23.
4. Hartung TK, Henry JA. Amphetamine and ectacy. In: Webb AR, Shapiro MJ, Singer M, Suter PM, eds. Oxford Textbook of Critical Care. Oxford: Oxford Med Publ, 1999: 637-9.
5. Chan T C, Evan SD, Clark RF. Drug-induced hyperthermia. Crit Care Clin 1997; 13: 785-808.
6. Khosla R, Kuntupalli KK. Heat-related illness. Crit Care Clin 1999; 15: 251-63.
7. Adnet PJ, Gronert GA. Malignant hyperthermia: Advance in diagnosis and treatment. Curr Opin Anesth 1999; 12: 353-8.
8. Halsall PJ, Ellis FR. Pathophysiology of malignant hyperthermia. In: Webb AR, Shapiro MJ, Singer M, Suter PM, eds. Oxford Textbook of Critical Care. Oxford: Oxford Med Publ, 1999: 801-3.
9. Bendahan D, Kozak-Ribbens G, Confort-Gouny S, et al. Noninvasive investigation of muscle energetics supports similarities between exertional heat stroke and malignant hyperthermia. Anesth Analg 2001; 93: 683-9.
10. Rosenberg H, Antognini JF, Muldoon S. Testing for malignant hyperthermia. Anesthesiology 2002; 96: 232-7.
11. th Ed. London: Edward Arnold, 1998: 932-52.
12. Leary NP, Ellis FR. Masseter muscle spasm as normal response to succinylcholine. Br J Anaesth 1990; 64: 488-92.
13. th Ed. Philadelphia: Churchill Livingstone, 2000: 1033-52.
14. Hopkins PM. Malignant hyperthermia: Advances in clinical management and diagnosis. Br J Anaesth 2000; 85: 118-28.
15. Halsall PJ, Ellis FR. Management of malignant hyperthermia. In: Webb AR, Shapiro MJ, Singer M, Suter PM, eds. Oxford Textbook of Critical Care. Oxford: Oxford Med Publ, 1999: 803-6.
16. Kirk H. The anesthetic myopathies and malignant hyperthermias. Curr Opin Neurol 1998; 11: 469-76.
17. Rosenberg H, Fletcher JE, Brandom BW. Malignant hyperthermia and other pharmacogenic disorders In: Barash PG, Cullen BF, Stoeling RK, eds. Clinical Anesthesia. Philadelphia: Lippincott Williams & Wilkins, 2001: 521-49.
18. Davies NP, Hanna MG. The skeletal muscle channelopathies: Basic science, clinical genetic and treatment. Curr Opin Neurol 2001; 14: 539-51.
19. rd Ed. NewYork: Lange Med Books/McGraw-Hill, 2002: 869-74.
20. Fawcett J, Busch KA. Stimulants in psychiatry. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Press Textbook of Psychopharmacology. Washington DC: Am Psychiatr Press, 1995: 417-34.
21. Fischer SP, Healzer JM, Brook MW, Brock-Utne JG. General anesthesia in the patient on long-term amphetamine therapy: Is there cause for concern? Anesth Analg 2000; 91: 758-9.
22. Miller NS. Amphetamines. In: Miller NS, ed. Comprehensive Handbook of Drugs and Alcohol Addiction. NewYork: Marcel Deckker Inc, 1991: 427-34.
23. Lane R, Baldwin D. Selective serotonin reuptake inhibitor induced serotonin syndrome. J Clin Psychopharmacol 1997; 17: 208-21.
24. King RG, Ellinwood EH. Amphetamines and other stimulants. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance Abuse a Comprehensive Textbook. Baltimore: Williams & Wilkins, 1992: 247-64.
25. Doyon S. The many faces of ecstasy. Curr Opin Pediatr 2001; 13: 170-6.
26. Michel R, Adams AP. Acute amphetamine abuse. Anaesthesia 1979; 34: 1061-9.
27. Shannon M. Methylenedioxymethamphetamine. MDMA. Pediatr Emerg Care 2000; 16: 377-80.
28. Burchell SA, Ho C, Yu M, Margulies DR. Effect of amphetamine on trauma patients: A cause of severe metabolic acidosis. Crit Care Med 2000; 28: 2112-5.
29. Screaton GR, Singer M, Cairns HS, et al. Hyperpyrexia and rhabdomyolysis after MDMA.(ecstasy) abuse. Lancet 1992; 339: 677-8.
30. MacKenzie RG, Heischober B. Methamphetamine. Pediatr Rev 1997; 18: 305-9.
31. Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intens Care Med 2001; 27: 803-11.
32. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol 2000; 11: 1553-61.